Design of novel urogenital pharmabiotic formulations containing lactobacilli,salivaricin CRL 1328 and non-microbial compounds with different functionalities

Context: The administration of pharmabiotics is a promising alternative to antimicrobial drugs for the treatment and/or prevention of female urogenital infections.

Objective: To design pharmabiotic formulations including bioactive ingredients of microbial origin combined with non-microbial substances and then to evaluate the stability of the combinations during freeze-drying and storage.

Materials and methods: Different formulations including Lactobacillus gasseri CRL 1263, Lactobacillus salivarius CRL 1328, salivaricin CRL 1328 (a bacteriocin) and non-microbial compounds (lactose, inulin and ascorbic acid) were assayed, and the ingredients were freeze-dried together or separately. The formulations were stored in gelatin capsules at 4?°C for 360?d.

Results: The viability of lactobacilli was affected to different extents depending on the strains and on the formulations assayed. L. salivarius and ascorbic acid were successfully combined only after the freeze-drying process. Salivaricin activity was not detected in formulations containing L. gasseri. However, when combined with ascorbic acid, lactose, inulin or L. salivarius, the bacteriocin maintained its activity for 360?d. The selected microorganisms proved to be compatible for their inclusion in multi-strain formulations together with lactose, inulin and ascorbic acid. Salivaricin could be included only in a L. salivarius CRL 1328 single-strain formulation together with non-microbial substances.

Conclusions: This study provides new insights into the design of urogenital pharmabiotics combining beneficial lactobacilli, salivaricin CRL 1328 and compounds with different functionalities.     

Interview mit Hans-Christian Boos zum Thema „Unternehmertum in der IT-Branche“

Ohne Zusammenfassung     

Proteine des Bienenhonigs

Zusammenfassung Die Isolierung der Saccharase (E.C. 3.2.1.20) aus den Proteinkonzentraten von Raps-, Tannen- und Zuckerfütterungshonig wird beschrieben. Die Abtrennung von anderen Enzymen, insbesondere von saurer Phosphatase gelingt durch hydrophobe Wechselwirkungschromatographie, von inerten Proteinen durch Gelfiltration. Im Zusammenhang damit wird das Verhalten des Enzyms bei der Chromatographie an Anionenaustauschern, an Hydroxylapatit und an immobilisiertem Weizenkeimlectin untersucht. Dabei ergab sich am Lectin-Gel eine Trennung in zwei multiple Formen.Die Saccharase aus allen drei Honigsorten verhielt sich einheitlich, woraus zu schließen ist, daß sie ausschließlich von der Biene stammt. Ihre Molekül masse wurde gelchromatographisch zu 57000 ermittelt.

---

The proteins of honeyVIII. Honey sucrase, isolation, chromatographic behaviour and properties

Summary The isolation of the honey sucrase (E.C. 3.2.1.20) from rape- and fir-honey as well as from honey obtained after sugar feeding is described. The separation from other honey enzymes especially from acid phosphatase succeded by reversed phase chromatography. Separation of other, non-active proteins was accomplished by gel permeation chromatography. The behaviour of the honey sucrase upon chromatography on anion exchangers, on hydroxylapatite and wheat germ lectin was investigated. No differences were found between the sucrases of the three honeys.The molecular weight was determined at 57 000. By affinity chromatography with wheat germ lectin the enzyme could be separated into two multiple forms.